BioMarin Pharmaceutical
BMRN
$83.86
Share price
-8.04%
Change (1 day)
-12.79%
Change (1 year)
Categories
EPS for BioMarin Pharmaceutical (BMRN)
EPS in 2023 (TTM): $0.78
According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is $0.78. In 2022 the company made an earnings per share (EPS) of $0.77 an increase over its 2021 EPS that were of -$0.35.
EPS history for BioMarin Pharmaceutical from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.78 | 1.3% |
| 2022 | $0.77 | -319.62% |
| 2021 | -$0.35 | -107.38% |
| 2020 | $4.74 | -3485.71% |
| 2019 | -$0.14 | -67.44% |
| 2018 | -$0.43 | -34.85% |
| 2017 | -$0.66 | -83.21% |
| 2016 | -$3.93 | 263.89% |
| 2015 | -$1.08 | 18.68% |
| 2014 | -$0.91 | -28.91% |
| 2013 | -$1.28 | 34.74% |
| 2012 | -$0.95 | 93.88% |
| 2011 | -$0.49 | -124.5% |
| 2010 | $2.00 | |
| 2009 | N/A | -100% |
| 2008 | $0.32 | -300% |
| 2007 | -$0.16 | -54.29% |
| 2006 | -$0.35 | -67.89% |
| 2005 | -$1.09 | -62.54% |
| 2004 | -$2.91 | 136.59% |
| 2003 | -$1.23 | -15.17% |
| 2002 | -$1.45 | -11.59% |
| 2001 | -$1.64 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $3.18 | 308.43% | 🇫🇷 France |
 Ultragenyx RARE | -$10.24 | -1,415.08% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | -$1.44 | -284.93% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -$2.82 | -462.16% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | -$0.64 | -182.19% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $1.10 | 41.27% | 🇺🇸 USA |